Article info

Download PDFPDF
Original article
Poly I:C-based rHBVvac therapeutic vaccine eliminates HBV via generation of HBV-specific CD8+ effector memory T cells

Authors

  1. Correspondence to Dr Jian Zhang, Institute of Immunopharmaceutical Sciences, School of Pharmaceutical Sciences, Shandong University, Shandong, 250012, China; zhangj65{at}sdu.edu.cn
View Full Text

Citation

Zhao H, Han Q, Wang G, et al
Poly I:C-based rHBVvac therapeutic vaccine eliminates HBV via generation of HBV-specific CD8+ effector memory T cells

Publication history

  • Received November 1, 2017
  • Revised November 24, 2018
  • Accepted December 4, 2018
  • First published January 11, 2019.
Online issue publication 
October 07, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.